Table 3. Relationship between the expression of the top 10 lncRNAs and clinicopathological factors in LUSC from TCGA.

LncRNA\factor	Dimension (small/large)		Smoking (no/yes)		T (T1/2 vs. T3/4)		N (no/yes)		M (no/yes)		Pathological stage (I/II vs III/IV)		Targeted molecular therapy (no/yes)
	t	P	t	P	t	P	t	P	t	P	t	P	t	P
SFTA1P	-2.236	0.026	-1.097	0.273	1.681	0.093	-2.670	0.008	1.182	0.238	0.020	0.984	-2.542	0.011
LINC00968	-2.752	0.006	-2.549	0.011	1.138	0.256	-0.269	0.788	0.950	0.343	0.989	0.323	-2.910	0.044
LINC00961	-3.169	0.002	-1.806	0.072	1.903	0.058	1.635	0.103	0.416	0.678	-0.553	0.581	-0.209	0.835
LINC01572	2.408	0.016	2.433	0.015	-0.096	0.924	3.012	0.003	1.959	0.051	-2.717	0.007	2.123	0.034
RP1-78O14.1	-3.597	<0.001	1.020	0.308	0.087	0.930	-2.250	0.025	0.644	0.520	1.137	0.246	-2.634	0.009
FENDRR	-1.058	0.290	-1.991	0.047	1.812	0.071	-0.588	0.536	0.603	0.547	1.133	0.258	-1.497	0.135
LINC01314	-1.036	0.301	-0.201	0.841	2.066	0.039	-3.880	<0.001	0.493	0.623	1.991	0.047	-2.335	0.020
LINC01272	-3.333	0.001	0.070	0.994	-0.672	0.502	-1.189	0.235	1.430	0.153	0.131	0.896	-1.367	0.172
GATA6-AS1	0.424	0.672	0.996	0.320	0.343	0.732	-0.623	0.534	-0.336	0.737	0.761	0.447	-1.716	0.087
MIR3945HG	-1.730	0.084	1.161	0.246	-0.118	0.907	-1.580	0.115	-0.517	0.605	1.371	0.171	-1.869	0.062

T: tumor stage; N: lymph node; M: metastasis